Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Complexa Inc patents


Recent patent applications related to Complexa Inc. Complexa Inc is listed as an Agent/Assignee. Note: Complexa Inc may have other listings under different names/spellings. We're not affiliated with Complexa Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Complexa Inc-related inventors


Antiviral and antibacteria agents based on quaternary ammonium compound complexed with boric acid and its derivatives

The present document describes compounds resulting from the complexation of quaternary ammonium compounds with boric acid and/or its derivatives, and methods of making the same, and methods of using the same for the treatment of pathogenic infections.. . ... Complexa Inc

Process for the production of graphene sheets with tunable functionalities from seaweed promoted by deep eutectic solvents

The present invention relates to the process for the scalable production of fe3o4/fe, sn & zn doped graphene nanosheets from a naturally abundant seaweed resources such as sargassum tenerrimum, sargassum wighti, ulva faciata, ulva lactuca and kappaphycus alvarezii. The granules remained after the recovery of liquid juice from the fresh seaweeds were utilized as a raw material and a deep eutectic solvents (dess) generated by the complexation of choline chloride and fecl3, zncl2 and sncl2 were employed as template as well as catalyst for the production graphene nanosheets functionalized with metals. ... Complexa Inc

Polymer nanofibers from electrospinning of complex coacervates, and compositions and methods thereof

The invention provides novel polymer nanofiber or microfiber mats or membranes and methods for their preparation via an aqueous, one-step polyelectrolyte complexation and electrospinning of complex coacervates.. . ... Complexa Inc

Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

Disclosed are methods, compounds, and compositions for treating infection by an apicomplexan parasite that include administering a compound that selectively inactivates ornithine aminotransferase of the apicomplexan parasite. Specifically, the methods, compounds, compounds may be utilized for treating infection by toxoplasma gondii and toxoplasmosis and for treating infection by plasmodium falciparum and malaria. ... Complexa Inc

Methods and systems employing a sulfonated iminodiacetic acid during subterranean treatment operations

In a subterranean formation, complexation of metal ions can often be desirable in order to mitigate reactivity of the metal ions. However, many chelating agents used for this purpose are commercially manufactured in an alkali metal salt form that may not be entirely suitable for use downhole. ... Complexa Inc

Modified cyclopentapeptides and uses thereof

The present invention, among others, relates to a compound having a structure according to formula (i) or a pharmaceutically acceptable salt thereof, wherein xaa1 are the iodo-substituted or methyl-substituted amino acids d- and l-tyr, iodo-substituted or methyl- substituted d- and l-homotyrosine, iodo-substituted or methyl-substituted d- and l-phe, iodo-substituted or methyl-substituted d- and l-p-oh-phenylglycine, and iodo-substituted or methyl-substituted d- or l-trp, xaa2 to xaa4 are independently of each other, an optionally n-alkylated natural or unnatural amino acid, r is h or methyl, l is a linker moiety, ar is a spacer comprising an aromatic moiety, and d comprises, preferably is i) a combination of an organic complexation agent and a radioactive or a detectable label; or ii) a radioactive or a detectable label, an organic complexation agent or an active substance, said active substance particularly being selected from cytotoxic agents, lipids, sugars, sugar conjugates, sugar derivatives, proteins and combinations thereof.. . ... Complexa Inc

Immolative cell-penetrating complexes for nucleic acid delivery

There are provided herein, inter alia, complexes, compositions and methods for the delivery of therapeutic, diagnostic and imaging agents, including nucleic acid, into a cell. The complexes, compositions and methods may facilitate complexation, protection, delivery and release of oligonucleotides and polyanionic cargos into target cells, tissues, and organs both in vitro and in vivo.. ... Complexa Inc

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

Wherein the variables x, y, z, l, r1, and r3 are defined herein.. . ... Complexa Inc

Formulations and methods for mineral scale removal

A composition is provided for sulfate scale removal, said composition comprising one or more chelants and one or more accelerants, wherein said accelerants serve to occupy reactive sites of cations of the sulfate scale. The composition is preferably provided wherein said one or more chelants comprise a mixture of two or more polyaminopolycarboxylic acids. ... Complexa Inc

Chromium alloy coating with enhanced resistance to corrosion in calcium chloride environments

The invention consists of a chromium electroplating solution comprising a chromium electroplating solution comprising: (1) a water soluble trivalent chromium salt; (2) at least one complexant for trivalent chromium ions; (3) a source of hydrogen ions sufficient to create a ph of from 2.8-4.2; (4) a ph buffering compound; and (5) a sulfur-containing organic compound. The chromium electroplating solution is usable in a method for producing an adherent metallic coating on a decorative article, such coating having enhanced resistance to corrosion in environments containing calcium chloride.. ... Complexa Inc

Targeted contrast agents comprising a hydrazide functional group

Described herein is a contrast agent for administration to a subject. The contrast agent includes a targeting portion that includes a hydrazide functional group; a metal ion bound to a metal-complexable portion; and a linker joining the targeting portion and the metal-complexable portion of the contrast agent. ... Complexa Inc

Nickel having high ligand-complexation activity and methods for making the same

Disclosed are nickel-containing complexation precursors having high complexation activity for bidentate processed under various conditions phosphite ligands. Also disclosed are methods of making the complexation precursors. ... Complexa Inc

Bifunctional do2pa derivatives, chelates with metallic cations and use thereof

Disclosed are chelates resulting from the complexation of bifunctional do2pa derivatives ligands of formula (i), wherein the substituents r1, r1′, r2, r2′, r3, r3′, l1, l1′, l2 and l2′ are defined as in the claims, with metallic cations, especially pb(ii) and bi(iii). Also disclosed are bifunctional do2pa derivatives ligands of formula (i), as well as the use of chelates in nuclear medicine and the use of ligands in cations detection or epuration of effluents.. ... Complexa Inc

Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Disclosed herein are pharmaceutically acceptable complex formulations comprising complexes of ivacaftor, or a salt or derivative thereof, together with complexation agents and pharmaceutically acceptable excipients; processes for the preparation thereof; and pharmaceutical compositions containing them. The complexes possess instantaneous redispersibility, increased apparent solubility and permeability compared to kalydeco, no observable food effect which deliver the opportunity of precise dosing and ease of administration of the reconstituted complex ivacaftor in solution form.. ... Complexa Inc

11/16/17 / #20170326121

Complexes of lumacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Disclosed herein are pharmaceutically acceptable complex formulations comprising complexes of lumacaftor, or a salt, or derivative thereof together with complexation agents and, optionally, pharmaceutically acceptable excipients; processes for the preparation thereof and pharmaceutical compositions containing them. The complex formulations have improved dissolution and permeability in fasted and fed state simulation that is expected to deliver full absorption and the elimination of the food effect.. ... Complexa Inc

11/02/17 / #20170313927

Composition for removing naturally occurring radioactive material (norm) scale

A composition is provided for the treatment of scaling and deposits due to naturally occurring radioactive material, said composition comprising one or more extractants that preferentially attract radioactive isotopes over other forms of alkaline earth cations a composition is further provided wherein said composition forms a polydentate ligand with one or more metals to act as carriers for radioactive elements. The composition comprises components that enhance stabilization of coordination complexation of the radioactive isotopes in the formation of polydentate ligands.. ... Complexa Inc

09/07/17 / #20170256366

Stable bromine charge storage in porous carbon electrodes using tetraalkylammonium bromides for reversible solidcomplexation

Electrolytes for use in electric double-layer capacitors (edlcs; often referred as supercapacitors or ultracapacitors) are disclosed. In one example, the electrolyte comprises viologen in both the anolyte and the catholyte (with bromide). ... Complexa Inc

09/07/17 / #20170253650

Anti-parasitic complexes

The technology provided herein relates to novel anti-parasitic complexes, in particular recombinant fusion proteins suitable as human and/or animal drugs against a parasite of the phylum apicomplexa, in particular against plasmodium falciparum (p. Falciparum) comprising at least one component a and at least one component b, characterized in that component a has a binding activity for cellular surface structures presented on the surface of a parasite of the phylum apicomplexa or for parasitic antigens presented on a parasitized host cell, and component b is a compound having anti-parasitic activity.. ... Complexa Inc

08/03/17 / #20170216462

Method for producing a liquid pharmaceutical preparation

A method for producing a liquid pharmaceutical preparation which contains a complex consisting of dota and gadolinium and a base such as l-lysine or meglumine, includes the following steps: a) an aqueous solution containing free dota, free gadolinium and a base such as l-lysine or meglumine is produced. B) the yield of free dota and free gadolinium is determined in the solution obtained according to step a). ... Complexa Inc

07/27/17 / #20170211023

Supramolecular capsules

Provided is the use of a capsule holding a catalyst, such as an enzyme. The capsule has a shell of material that is a supramolecular cross-linked network. ... Complexa Inc

06/29/17 / #20170182136

Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection

Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine vectors include a polynucleotide encoding a rhomboid polypeptide and optionally include an immune-stimulatory polypeptide suitably expressed on the surface of the vaccine vector.. ... Complexa Inc

06/15/17 / #20170166993

Ligand assisted chromatography for metal ion separation

Presented herein is a ligand-assisted elution chromatography process for the separation of metal ions using a sorbent. An inorganic sorbent, titania, for example, has three types of adsorption sites: bronsted acid (ba), bronsted base (bb), and lewis acid (la). ... Complexa Inc

06/01/17 / #20170151350

Phosphorescent nanoparticles and their uses in biosensing and bioimaging

Size-tunable phosphorescent particles may be formed through self-assembly of biocompatible linear polymers, such as chitosan and other linear polymers, that bear positive surface charges, through polyelectrolytic complexation to a polyanionic metal phosphor, such as polyanionic gold(i) phosphor (aup). The phosphorescent hydrogel nanoparticles and thin films thereof are useful for imaging, sensing of biological molecules, detection of hypoxia, and light-emitting devices. ... Complexa Inc

05/18/17 / #20170137473

Fluorogen activating and shifting tag (fast)

Disclosed is a functional derivative of a photoactive yellow protein (pyp), or a functional fragment thereof, for fluorescently labelling particles, e.g. Proteins, or surfaces, which is capable of binding reversibly a fluorogenic chromophore of formula (i), and which is capable of enhancing the brightness of the fluorogenic chromophore upon complexation thereto; and of inducing the spectral shift of the fluorogenic chromophore through the ionization of an auxochromic group thereof.. ... Complexa Inc

05/11/17 / #20170129999

Ph responsive self-healing hydrogels formed by boronate-catechol complexation

Biocompatible hydrogels made from cross-linked catechol-borate ester polymers are disclosed, along with methods of synthesizing and using such hydrogels. The hydrogels of the present invention are prepared by boronic acid-catechol complexation between catechol-containing macromonomers and boronic acid-containing cross-linkers. ... Complexa Inc

05/04/17 / #20170125261

Method of etching transition metal film and substrate processing apparatus

Disclosed is a method of anisotropically etching a transition metal film using a substrate processing apparatus including at least one processing container configured to perform a processing on a workpiece including the transition metal film. The method includes an oxidation step of introducing a first gas containing an oxygen ion into the processing container and irradiating the transition metal film with the oxygen ion to oxidize a transition metal of the transition metal film, thereby forming a metal oxide layer; and a complexation/etching step of introducing a second gas for complexation of the metal oxide layer into the processing container and forming a metal complex in the metal oxide layer, thereby performing an etching.. ... Complexa Inc

04/20/17 / #20170106106

Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy

The invention relates to octadentate ligands of a general formula r1-d-x-d-x-d-x-d-e-r2, wherein d is c(o)n(oh) or n(oh)c(o), pyrimidinone or pyridinone, each x independently of any other x is a saturated or partially unsaturated, substituted or unsubstituted linker comprising 8-11 atoms selected from any of n, c, o; r1 is alkyl, cycloalkyl, arene, or heteroarene, e is a saturated or partially unsaturated, substituted or unsubstituted chain comprising 1-50 atoms and r2 is a moiety capable of selectively binding to a biomolecule, or a nanoparticle. The invention further relates to complexes of the ligand, particularly radionuclides and their use in radioimmunotherapy and imaging.. ... Complexa Inc

04/06/17 / #20170098560

Slurry composition for chemical mechanical polishing of ge-based materials and devices

A cmp slurry composition which provides for a high ge- or sige-to-dielectric material selectivity a low rate of ge or sige recess formation includes an oxidant and a germanium removal rate enhancer including at least one of a methylpyridine compound and a methylpyridine derivative compound. In some examples, the slurry composition also includes an etching inhibitor. ... Complexa Inc

04/06/17 / #20170095437

Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids

Various embodiments of this invention are directed to pharmaceutical compositions and methods for treating diseases, including focal segmental glomerulosclerosis or pulmonary arterial hypertension. The compositions of such embodiments include activated fatty acids such as alkyl substituted fatty acids, keto fatty acids and nitro fatty acids. ... Complexa Inc

03/30/17 / #20170087230

Novel methods for freeze-drying and rehydrating biologics

The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. ... Complexa Inc

03/09/17 / #20170066957

Non-reducing stabilization complexant for acidizing compositions and associated methods

Methods for reducing viscosifying tendencies of crude oil in subterranean formations using solid acid chelating agents are described. The methods include combining a solid acid chelating agent and an aqueous acid solution to form a treatment fluid, and introducing the treatment fluid into the subterranean formation. ... Complexa Inc

03/02/17 / #20170056389

5-aminopyrazole-4-carboxamide inhibitors of cdpk1 from t. gondii and c. parvum

The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.. . ... Complexa Inc

02/23/17 / #20170050147

Complexation and removal of mercury from flue gas desulfurization systems

A method for the reduction and prevention of mercury emissions into the environment from combusted fossil fuels or off-gases having mercury with the use of hypoiodite is disclosed. The hypoiodite is used for the capture of mercury from the resulting flue gases using a flue gas desulfurization system or scrubber. ... Complexa Inc

02/23/17 / #20170050146

Complexation and removal of mercury from flue gas desulfurization systems

A method for the reduction and prevention of mercury emissions into the environment from combusted fossil fuels or other off-gases with the use of peracetic acid is disclosed. The peracetic acid is used for the capture of mercury from the resulting flue gases using a flue gas desulfurization system or scrubber. ... Complexa Inc

02/23/17 / #20170050145

Complexation and removal of mercury from flue gas desulfurization systems

A method for the reduction and prevention of mercury emissions into the environment from combusted fossil fuels or other off-gases with the use of hypobromite is disclosed. The hypobromite is used for the capture of mercury from the resulting flue gases using a flue gas desulfurization system or scrubber. ... Complexa Inc

02/16/17 / #20170044150

Identification of compounds which inhibit atg8-atg3 protein-protein interaction and their use as antiparasitical agents

The present invention provides compounds or a pharmaceutically acceptable salts, solvates, stereoisomers, or prodrugs thereof which can block the atg8-atg3 protein-protein interaction, which is associated with autophagy in apicomplexan organisms. Pharmaceutical compositions comprising these compounds and their use for the suppression and treatment of various parasitical diseases are also provided.. ... Complexa Inc

02/16/17 / #20170042829

Methods of preparing polyelectrolyte complex nanoparticles

The presently disclosed subject matter provides methods for continuously generating uniform polyelectrolyte complex (pec) nanoparticles comprising: flowing a first stream comprising one or more water-soluble polycationic polymers at a first variable flow rate into a confined chamber; flowing a second stream comprising one or more water-soluble polyanionic polymers at a second variable flow rate into the confined chamber; and impinging the first stream and the second stream in the confined chamber until the reynolds number is from about 1,000 to about 20,000, thereby causing the one or more water-soluble polycationic polymers and the one or more water-soluble polyanionic polymers to undergo a polyelectrolyte complexation process that continuously generates pec nanoparticles. Compositions produced from the presently disclosed methods and a device for producing the compositions are also disclosed.. ... Complexa Inc

02/02/17 / #20170028374

Supramolecular capsules

Provided is a capsule having a shell of material that is a supramolecular cross-linked network. The network is formed from a host-guest complexation of cucurbituril (the host) and one or more building blocks comprising suitable guest functionality. ... Complexa Inc

01/26/17 / #20170021035

Nanosized carotenoid cyclodextrin complexes

Methods for the preparation of nanosized nutrient formulations for enhanced absorption of nutritional agents. The methods include the complexation of cyclodextrin with carotenoids and incorporation of the complexes into the nutritional supplements without intermediate collection, isolation, and drying steps.. ... Complexa Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Complexa Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Complexa Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###